An AI-based ‘robot scientist’ called Eve, developed by scientists at the Universities of Manchester, Aberystwyth and Cambridge, has aided researchers in discovering that the toothpaste ingredient triclosan could be used to fight drug-resistant malaria.                

The system was programmed to automatically develop and test hypotheses to explain observations and run experiments by using other robotics in the lab.

It could then interpret the results of the experiments and amend the original hypothesis and repeat the cycle.

The significance of Eve’s discovery

Malaria is responsible for half a million deaths a year.

It is caused by parasites of the genus Plasmodium, which are carried by mosquitoes and have several distinct stages in vertebrate hosts.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The only anti-malarials that target all of these stages cause severe side effects.

Triclosan is already known to be safe, as it is an active ingredient in many toothpastes, but until Eve’s discovery, scientists had only proven that triclosan could target the Plasmodium catalyst in the liver stage of the parasite.

Using high-throughput screening, Eve discovered that triclosan can also target the Plasmodium catalyst in the blood stages, even in parasites that have become resistant to available drugs.

The machine learning that the AI-driven robot scientist demonstrated could greatly speed up the drug development process, reduce costs and aid in more discoveries like triclosan.